Deborah Siegal/LinkedIn
Mar 1, 2026, 10:31
Deborah Siegal Explores ARTESiA in The CLOT Conversation’s Latest Episode
Thrombosis Canada shared on LinkedIn:
”Major bleeding remains the leading complication of oral anticoagulation.
In our latest episode of CLOT Conversations, Dr. Deborah Siegal discusses the ARTESiA subanalysis examining major bleeding with apixaban versus aspirin in patients with device-detected subclinical atrial fibrillation.
Key insights:
- Apixaban reduced stroke/systemic embolism by 37%
- Major bleeding increased, largely driven by gastrointestinal events
- Intracranial and fatal bleeding rates were low and similar
- Most bleeding events were not clinical emergencies
- NSAID use emerged as a key modifiable risk factor
Understanding not just how often bleeding occurs, but how severe it is, is critical to individualized risk assessment and shared decision-making.”
Stay updated with Hemostasis Today.
-
Jul 19, 2026, 16:59Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
-
Jul 19, 2026, 16:58Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
-
Jul 19, 2026, 16:58Aviva Schwartz: Air Pollution and Women’s Hematological Health in the Spotlight at ISTH 2026
-
Jul 19, 2026, 16:56Lola Sepot-Boucherit: Reimagining the Future of Rare Bleeding Disorders at ISTH 2026
-
Jul 19, 2026, 16:54Belén de la Morena Barrio: Presenting Our Research on Long-Read Sequencing for Genetic Diagnosis at ISTH 2026
-
Jul 19, 2026, 16:52Shamee Shastry: Sometimes the Answer is Not in the Test Tube Alone, but at the Patient’s Bedside
-
Jul 19, 2026, 16:52Manuela Albisetti: Congratulations to Alessandra Bosch on an Outstanding ISTH 2026 Talk
-
Jul 19, 2026, 16:44Fernanda Orsi: A Memorable Week of Science and Collaboration at ISTH 2026
-
Jul 19, 2026, 16:37William Aird: A Visual Guide to Understanding von Willebrand Disease